Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8501 - 8525 of 10763 in total
Experimental
Matched Name: … 5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE …
Matched Iupac: … 5-cyano-N-[5-(hydroxymethyl)-2-(4-methylpiperidin-1-yl)phenyl]furan-2-carboxamide …
Experimental
Matched Name: … 4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid …
Matched Iupac: … 2-[4-(benzenesulfonyl)thiophene-2-sulfonamido]-4-(dihydroxyboranyl)benzoic acid …
Experimental
Matched Name: … 1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL …
Matched Iupac: … 1-chloro-6-(4-hydroxyphenyl)naphthalen-2-ol …
Experimental
Matched Name: … 2-aminoethyl naphthalen-1-ylacetate …
Matched Iupac: … 2-aminoethyl 2-(naphthalen-1-yl)acetate …
Experimental
Matched Name: … 2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID …
Matched Iupac: … 2-[(1E)-2-(4-hydroxynaphthalen-1-yl)diazen-1-yl]benzoic acid …
Experimental
Matched Name: … Methyl N-{[(1R)-1-({1-[(benzyloxy)carbonyl]-L-prolyl-6-ammonio-L-norleucyl}amino)-2-phenylethyl](hydroxy …
Matched Iupac: … [(1R)-1-[(2S)-6-azaniumyl-2-{[(2S)-1-[(benzyloxy)carbonyl]pyrrolidin-2-yl]formamido}hexanamido]-2-phenylethyl ... ]({[(2S)-1-[(2S)-2-(methoxycarbonyl)pyrrolidin-1-yl]-1-oxopropan-2-yl]amino})phosphinic acid …
Experimental
Matched Name: … 4-(Carboxyvin-2-Yl)Phenylboronic Acid …
Matched Iupac: … (2E)-3-[4-(dihydroxyboranyl)phenyl]prop-2-enoic acid …
Experimental
Matched Iupac: … (2R,3R,4S,5R,6S)-3,4,6-trihydroxy-5-(sulfooxy)oxane-2-carboxylic acid …
Experimental
Matched Name: … 2-[(Dioxidophosphoranyl)oxy]benzoate …
Matched Iupac: … 2-[(oxidophosphonoyl)oxy]benzoate …
Experimental
Matched Name: … 2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE …
Matched Iupac: … [2-(4-methylphenoxy)ethyl]phosphinate …
BNT162b1 is one of four advanced mRNA-based vaccines being developed through "Project Lightspeed," a joint program between Pfizer and BioNTech.[L15002, L15007] BNT162b1 is a nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein together with a "foldon" trimerization domain derived from T4 fibritin...
Investigational
Matched Name: … BNT162b1 SARS-CoV-2 Vaccine …
Matched Description: … nucleoside modified mRNA (modRNA) vaccine encoding the receptor-binding domain (RBD) of the SARS-CoV-2 ... [L15007, L15012] Early results from a phase 1/2 study in 45 healthy adult volunteers demonstrated RBD-binding …
Experimental
Matched Name: … 2-Phenylamino-Ethanesulfonic Acid …
Matched Iupac: … 2-(phenylamino)ethane-1-sulfonic acid …
Experimental
Matched Iupac: … {[(2S,3S,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]methoxy}phosphonic acid …
Experimental
Matched Synonyms: … 5-naphthylamine-2-sulfonic acid ... 5-aminonaphthalene-2-sulphonic acid …
Matched Name: … 5-aminonaphthalene-2-sulfonic acid …
Matched Iupac: … 5-aminonaphthalene-2-sulfonic acid …
Experimental
Matched Name: … 4-(2-AMINOETHYL)BENZENESULFONAMIDE …
Matched Iupac: … 4-(2-aminoethyl)benzene-1-sulfonamide …
Investigational
CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.
Experimental
Investigational
Experimental
Matched Synonyms: … 2(10)-pinene …
Matched Iupac: … 6,6-dimethyl-2-methylidenebicyclo[3.1.1]heptane …
Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics investigated against dry eye disease, allergic conjunctivitis, noninfectious anterior uveitis, and Sjögren-Larsson syndrome. NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome.
Investigational
Matched Synonyms: … NS-2
Matched Iupac: … 2-(3-amino-6-chloroquinolin-2-yl)propan-2-ol …
Matched Description: … Reproxalap (previously ADX 102 or NS-2) is a small molecule inhibitor being developed by Aldeyra Therapeutics ... [L32990] NS-2 has orphan drug status due to it being investigated for treatment of Sjogren-Larsson syndrome …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Investigational
Matched Iupac: … -tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1^{5,8}.1^{10,13}.1^{15,18}.0^{2,6}]hexacosa-1(23),2( …
The CVnCov Vaccine (or CV07050101) is in development by CureVac AG. The vaccine uses mRNA technology to create a protein associated with SARS-CoV2, and upon administration and replication, to initiate subsequent immune responses in the body. As of June 2020, the company received regulatory approval from German and Belgian Authorities...
Investigational
Matched Synonyms: … SARS-CoV-2 mRNA vaccine …
Experimental
Matched Name: … 4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14 …
Experimental
Matched Synonyms: … 2-Hydroxy-5-nitrophenyl sulfate ... 2-hydroxy-5-nitrophenyl hydrogen sulfate …
Matched Iupac: … (2-hydroxy-5-nitrophenyl)oxidanesulfonic acid …
Experimental
Matched Synonyms: … 4-(4-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid ... 4-(p-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid …
Matched Iupac: … 2-[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid …
Matched Categories: … Non COX-2 selective NSAIDS …
Pegadricase is under investigation in clinical trial NCT01021241 (Safety and Efficacy Study of Intravenous Uricase-PEG 20).
Investigational
Displaying drugs 8501 - 8525 of 10763 in total